The New Digital Era for Formulation Development

Development of any new drug product from concept to commercialization requires detailed understanding of drug properties, excipients, manufacturing processes, analytical methods, and regulatory requirements in target markets. Solid oral dosage forms are the preferred delivery route, and it is vital to select the right core excipients early in the development process to ensure stability, performance quality attributes, patient acceptance, and manufacturability.

Self-service digital platforms are designed to address the complexity of developing a new drug product, through automating formulation and process recommendations.

Read this article in Pharmaceutical Technology®’s Trends in Formulation 2023 eBook.

About the authors

Shahrzad Missaghi, PhD, is senior manager—Product Development, and Jason Hansell is global technical excellence manager; both at Colorcon.

Article details

Pharmaceutical Technology
eBook: Trends in Formulation 2023
October 2023
Pages: 4–10

Citation

When referring to this article, please cite it as Missaghi, S.; Hansell, J. The New Digital Era for Formulation Development. Pharmaceutical Technology's Trends in Formulation 2023 eBook (October 2023).